News

It comes amid reports that the drugs maker is considering moving its listing from the UK to the US in what would be a hammer ...
Bengaluru: AstraZeneca is reportedly in discussions with Summit Therapeutics to license an experimental lung cancer drug in a ...
Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...
ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
The Cambridge, England-based pharmaceutical company said Imfinzi has been approved in the EU for treatments in adults with resectable muscle-invasive bladder cancer. The approval is for the use of ...
Experts and agencies reject any link between COVID-19 vaccines and sudden cardiac deaths, citing studies showing no causal ...
Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ...
Bengaluru: A war of words has erupted between Biocon founder Kiran Mazumdar-Shaw and Karnataka Chief Minister Siddaramaiah on ...
DelveInsight's Rheumatoid Arthritis Pipeline report depicts a robust space with 75+ active players working to develop 80+ ...
US President Donald Trump said he plans to start sending letters informing trading partners of their tariff rates.